文章摘要
唐一萍,冯 俊,彭 涛,李志勇,马 鹏,罗德艳.喉鳞状细胞癌组织miR-1207-5p、miR-186-5p表达水平与PI3K/Akt信号通路、临床病理特征和预后的关系[J].,2023,(22):4241-4246
喉鳞状细胞癌组织miR-1207-5p、miR-186-5p表达水平与PI3K/Akt信号通路、临床病理特征和预后的关系
Relationship between the Expression Levels of miR-1207-5p and miR-186-5p in Laryngeal Squamous Cell Carcinoma Tissue and PI3K/Akt Signaling Pathway, Clinicopathological Features and Prognosis
投稿时间:2023-05-23  修订日期:2023-06-11
DOI:10.13241/j.cnki.pmb.2023.22.008
中文关键词: 喉鳞状细胞癌  miR-1207-5p  miR-186-5p  PI3K/Akt信号通路  临床病理特征  预后
英文关键词: Laryngeal squamous cell carcinoma  MiR-1207-5p  MiR-186-5p  PI3K/Akt signaling pathway  Clinicopathological features  Prognosis
基金项目:四川省教育厅基金重点项目(18ZA0203)
作者单位E-mail
唐一萍 川北医学院第二临床医学院/南充市中心医院耳鼻咽喉头颈外科 四川 南充 637000 enttangyiping@163.com 
冯 俊 川北医学院第二临床医学院/南充市中心医院耳鼻咽喉头颈外科 四川 南充 637000  
彭 涛 川北医学院第二临床医学院/南充市中心医院耳鼻咽喉头颈外科 四川 南充 637000  
李志勇 川北医学院第二临床医学院/南充市中心医院耳鼻咽喉头颈外科 四川 南充 637000  
马 鹏 川北医学院第二临床医学院/南充市中心医院耳鼻咽喉头颈外科 四川 南充 637000  
罗德艳 川北医学院第二临床医学院/南充市中心医院耳鼻咽喉头颈外科 四川 南充 637000  
摘要点击次数: 296
全文下载次数: 197
中文摘要:
      摘要 目的:探讨喉鳞状细胞癌(LSCC)组织miR-1207-5p、miR-186-5p表达水平与磷脂酰肌醇3-激酶/蛋白激酶B(PI3K/Akt)信号通路、临床病理特征和预后的关系。方法:选取2017年1月至2020年1月南充市中心医院收治的120例LSCC患者,取手术切除的LSCC组织和癌旁组织。检测miR-1207-5p、miR-186-5p、PI3K mRNA、Akt mRNA表达。患者出院后随访3年,统计总生存(OS)和无复发生存(RFS)情况。分析miR-1207-5p、miR-186-5p与PI3K、Akt的相关性以及影响LSCC患者预后的因素。结果:LSCC组织miR-1207-5p、miR-186-5p表达低于癌旁组织(P<0.05),PI3K mRNA、Akt mRNA表达高于癌旁组织(P<0.05)。LSCC组织miR-1207-5p、miR-186-5p表达与PI3K mRNA、Akt mRNA表达呈负相关(P<0.05)。肿瘤直径≥1 cm、低分化、TNM分期Ⅲ期、颈部淋巴结转移LSCC组织中miR-1207-5p、miR-186-5p表达低于肿瘤直径<1 cm、中高分化、TNM分期Ⅰ~Ⅱ期、无颈部淋巴结转移(P<0.05)。miR-1207-5p低表达、miR-186-5p低表达LSCC患者3年总生存(OS)率和无复发生存(RFS)率低于miR-1207-5p高表达、miR-186-5p高表达LSCC患者(P<0.05)。多因素COX回归分析显示TNM III期、颈部淋巴结转移是LSCC患者复发和死亡的危险因素(P<0.05),高miR-1207-5p、高miR-186-5p是保护因素(P<0.05)。结论:LSCC组织中miR-1207-5p和miR-186-5p表达均下调,与LSCC恶性病理特征、PI3K/Akt信号通路激活以及低生存率有关。
英文摘要:
      ABSTRACT Objective: To investigate the relationship between the expression levels of miR-1207-5p and miR-186-5p in laryngeal squamous cell carcinoma (LSCC) tissue and the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway, clinicopathological features and prognosis. Methods: 120 patients with LSCC admitted to Nanchong Central Hospital from January 2017 to January 2020 were selected, and the surgically resected LSCC tissue and paracancer tissue were taken . The expression of miR-1207-5p, miR-186-5p, PI3K mRNA and Akt mRNA were detected. After discharge, the patient was followed up for 3 years to calculate the overall survival (OS) and recurrence free survival (RFS). The correlation of miR-1207-5p and miR-186-5p with PI3K and Akt and the factors affecting the prognosis of LSCC patients were analyzed. Results: The expressions of miR-1207-5p and miR-186-5p in LSCC tissue were lower than those in paracancer tissue(P<0.05), and the expressions of PI3K mRNA and Akt mRNA in LSCC tissue were higher than those in paracancer tissue (P<0.05). The expressions of miR-1207-5p and miR-186-5p in LSCC tissue were negatively correlated with the expressions of PI3K mRNA and Akt mRNA(P<0.05). The expressions of miR-1207-5p and miR-186-5p in LSCC tissue with tumor diameter ≥1 cm, poorly differentiated, TNM stage Ⅲ, and cervical lymph node metastasis were lower than those in LSCC tissue with tumor diameter < 1 cm, medium and highly differentiated, TNM stage Ⅰ to Ⅱ, and no cervical lymph node metastasis (P<0.05). The 3-year overall survival (OS) rate and relapse-free survival (RFS) rate of LSCC patients with low expression of miR-1207-5p and low expression of miR-186-5p were lower than those with high expression of miR-1207-5p and high expression of miR-186-5p LSCC patients(P<0.05). Multivariate COX regression analysis showed that TNM stage III and cervical lymph node metastasis were risk factors for recurrence and death in LSCC patients (P<0.05), and high miR-1207-5p, high miR-186-5p were protective factors (P<0.05). Conclusion: The down-regulated expression of miR-1207-5p and miR-186-5p in LSCC tissue were related to the malignant pathological characteristics of LSCC, activation of PI3K/Akt signaling pathway and low survival rate.
查看全文   查看/发表评论  下载PDF阅读器
关闭